Table 2.
Baseline clinical and immunological status of HIV positive adults at initiation of HAART, University of Gondar Referral Hospital from January 2010 to December 2014 (n = 410)
Characteristics | Frequency | Percent |
---|---|---|
Initial regimen | ||
AZT-3TC-NVP | 177 | 43.2 |
TDF-3TC-EFV | 147 | 35.9 |
AZT-3TC-EFV | 37 | 9 |
TDF-3TC-NVP | 28 | 6.8 |
D4T(30)-3TC-NVP | 16 | 3.9 |
D4T(30)-3TC-EFV | 3 | 0.7 |
ABC-3TC-EFV | 2 | 0.5 |
Number of ART pill/day | ||
One | 128 | 31.2 |
Two | 201 | 49 |
Three | 40 | 9.8 |
Four | 41 | 10 |
CPT prophylaxis | ||
Yes | 401 | 97.8 |
No | 9 | 2.2 |
Past OI before HARRT initiation | ||
No | 295 | 72 |
Yes | 115 | 28 |
Functional status | ||
Working | 361 | 88 |
Ambulatory | 29 | 7.1 |
Bed ridden | 20 | 4.9 |
WHO clinical stage | ||
I | 105 | 25.6 |
II | 73 | 17.8 |
III | 172 | 42 |
IV | 60 | 14.6 |
CD4 count | ||
<100 cell/mm3 | 110 | 26.8 |
100–199 cell/mm3 | 150 | 36.6 |
200–349 cell/mm3 | 133 | 32.4 |
≥350 cell/mm3 | 17 | 4.1 |
Baseline Hgb | ||
<7 g/dl | 8 | 2 |
7–9.9 g/dl | 37 | 9 |
10–12.9 g/dl | 173 | 42.2 |
≥13 g/dl | 192 | 46.8 |
Base line weight | ||
<60 kg | 318 | 77.6 |
≥60 kg | 92 | 22.4 |